Immunity to TB and targets for immunotherapy.

Immunotherapy
Mercedes Gonzalez-Juarrero

Abstract

For centuries the treatment of TB has presented an enormous challenge to global health. In the 20th century, the treatment of TB patients with long-term multidrug therapy gave hope that TB could be controlled and cured; however, contrary to these expectations and coinciding with the emergence of AIDS, the world has witnessed a rampant increase in hard-to-treat cases of TB, along with the emergence of highly virulent and multidrug-resistant Mycobacterium tuberculosis strains. Unfortunately, these bacteria are now circulating around the world, and there are few effective drugs to treat them. As a result, the prospects for improved treatment and control of TB in the 21st century have worsened and we urgently need to identify new therapies that deal with this problem. The potential use of immunotherapy for TB is now of greater consideration than ever before, as immunotherapy could potentially overcome the problem of drug resistance. TB immunotherapy targets the already existing host anti-TB immune response and aims to enhance killing of the bacilli. For this purpose, several approaches have been used: the use of anti-Mycobacteria antibodies; enhancing the Th1 protective responses by using mycobacterial antigens or increasing Th1 cy...Continue Reading

References

Oct 1, 1984·Arthritis and Rheumatism·O Gutiérrez-Rodríguez
Mar 1, 1996·Transactions of the Royal Society of Tropical Medicine and Hygiene·N KennedyS H Gillespie
Jul 23, 1998·Infection and Immunity·K LyashchenkoM L Gennaro
Oct 14, 1998·American Journal of Respiratory and Critical Care Medicine·S GiosuéF Ameglio
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·R TeitelbaumB R Bloom
Feb 9, 1999·Novartis Foundation Symposium·B JohnsonG Kaplan
May 8, 1999·Immunology·T KanellosP H Russell
Jun 24, 1999·Immunology Today·I M Orme, A M Cooper
Jun 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R D WaddellC F von Reyn
Apr 9, 2001·Infection and Immunity·J TurnerI M Orme
Jun 13, 2001·Infection and Immunity·K SamanichS Laal
Aug 8, 2001·The European Respiratory Journal·U GreinertP Entzian
May 23, 2002·Antimicrobial Agents and Chemotherapy·Liana TsenovaGilla Kaplan
Jul 3, 2002·Clinical and Diagnostic Laboratory Immunology·Rodrigo Ribeiro-RodriguesChristina S Hirsch
Nov 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joanne TurnerAndrea M Cooper
Mar 29, 2003·The European Respiratory Journal·T SchönT Sundqvist
Apr 19, 2003·American Journal of Respiratory and Critical Care Medicine·John L JohnsonUNKNOWN Uganda-Case Western Reserve University Research Collaboration
Jun 21, 2003·The American Journal of Clinical Nutrition·Tesfaye MadeboRolf K Berge
Sep 4, 2003·The Journal of Experimental Medicine·Martin I VoskuilGary K Schoolnik
Oct 15, 2003·FEMS Immunology and Medical Microbiology·Aharona Glatman-Freedman
Nov 26, 2003·Infection and Immunity·Gilla KaplanLinda-Gail Bekker

❮ Previous
Next ❯

Citations

Oct 27, 2015·EBioMedicine·Jacqueline M AchkarEustache Paramithiotis
Jun 1, 2015·Journal of Pharmacokinetics and Pharmacodynamics·Michael A Lyons, Anne J Lenaerts
Mar 23, 2018·Experimental Lung Research·Y López-HernándezR Hernandez-Pando
Sep 1, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kerstin WalterStefan Ehlers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.